Binding of the Human 14-3-3 Isoforms to Distinct Sites in the Leucine-Rich Repeat Kinase 2
出版年份 2020 全文链接
标题
Binding of the Human 14-3-3 Isoforms to Distinct Sites in the Leucine-Rich Repeat Kinase 2
作者
关键词
-
出版物
Frontiers in Neuroscience
Volume 14, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-04-07
DOI
10.3389/fnins.2020.00302
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Parkinson’s disease-associated mutations in the GTPase domain of LRRK2 impair its nucleotide-dependent conformational dynamics
- (2019) Chun-Xiang Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Stapled Peptide Mimic of the Pseudosubstrate Inhibitor PKI Inhibits Protein Kinase A
- (2019) Jascha T. Manschwetus et al. MOLECULES
- The dynamic switch mechanism that leads to activation of LRRK2 is embedded in the DFGψ motif in the kinase domain
- (2019) Sven H. Schmidt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Downregulation of 14-3-3 Proteins in Alzheimer’s Disease
- (2019) Qiang Gu et al. MOLECULAR NEUROBIOLOGY
- Regulation of LRRK2: insights from structural and biochemical analysis
- (2018) Bernd K. Gilsbach et al. BIOLOGICAL CHEMISTRY
- LRRK2 activation in idiopathic Parkinson’s disease
- (2018) Roberto Di Maio et al. Science Translational Medicine
- A Thermodynamic Model for Multivalency in 14-3-3 Protein–Protein Interactions
- (2018) Loes M. Stevers et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- UniProt: a worldwide hub of protein knowledge
- (2018) NUCLEIC ACIDS RESEARCH
- GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2
- (2017) Marian Blanca Ramírez et al. HUMAN MOLECULAR GENETICS
- LRRK2 phosphorylates membrane-bound Rabs and is activated by GTP-bound Rab7L1 to promote recruitment to the trans-Golgi network
- (2017) Zhiyong Liu et al. HUMAN MOLECULAR GENETICS
- Modulators of 14-3-3 Protein–Protein Interactions
- (2017) Loes M. Stevers et al. JOURNAL OF MEDICINAL CHEMISTRY
- PAK6 Phosphorylates 14-3-3γ to Regulate Steady State Phosphorylation of LRRK2
- (2017) Laura Civiero et al. Frontiers in Molecular Neuroscience
- The discovery ofLRRK2p.R1441S, a novel mutation for Parkinson's disease, adds to the complexity of a mutational hotspot
- (2016) Ignacio F. Mata et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- A dual phosphorylation switch controls 14-3-3-dependent cell surface expression of TASK-1
- (2016) Markus Kilisch et al. JOURNAL OF CELL SCIENCE
- Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
- (2016) Martin Steger et al. eLife
- LRRK2 dephosphorylation increases its ubiquitination
- (2015) Jing Zhao et al. BIOCHEMICAL JOURNAL
- 14-3-3-Pred: improved methods to predict 14-3-3-binding phosphopeptides
- (2015) Fábio Madeira et al. BIOINFORMATICS
- 14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening
- (2015) Nicholas J. Lavalley et al. HUMAN MOLECULAR GENETICS
- Increased 14-3-3 phosphorylation observed in Parkinson's disease reduces neuroprotective potential of 14-3-3 proteins
- (2015) Sunny Rae Slone et al. NEUROBIOLOGY OF DISEASE
- LRRK2 pathobiology in Parkinson's disease
- (2014) Ian Martin et al. JOURNAL OF NEUROCHEMISTRY
- Heterogeneity of Leucine-Rich Repeat Kinase 2 Mutations: Genetics, Mechanisms and Therapeutic Implications
- (2014) Iakov N. Rudenko et al. Neurotherapeutics
- Phosphorylation of LRRK2 by casein kinase 1α regulates trans-Golgi clustering via differential interaction with ARHGEF7
- (2014) Ruth Chia et al. Nature Communications
- Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle
- (2013) Evy Lobbestael et al. BIOCHEMICAL JOURNAL
- LRRK2 secretion in exosomes is regulated by 14-3-3
- (2013) K. B. Fraser et al. HUMAN MOLECULAR GENETICS
- Parkinson-related LRRK2 mutation R1441C/G/H impairs PKA phosphorylation of LRRK2 and disrupts its interaction with 14-3-3
- (2013) K. Muda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation
- (2012) Iakov N. Rudenko et al. BIOCHEMICAL JOURNAL
- LRRK2 Parkinson disease mutations enhance its microtubule association
- (2011) Lauren R. Kett et al. HUMAN MOLECULAR GENETICS
- Phosphorylation of LRRK2 serines 955 and 973 is disrupted by Parkinson’s disease mutations and LRRK2 pharmacological inhibition
- (2011) Elizabeth A. Doggett et al. JOURNAL OF NEUROCHEMISTRY
- Phosphorylation-Dependent 14-3-3 Binding to LRRK2 Is Impaired by Common Mutations of Familial Parkinson's Disease
- (2011) Xianting Li et al. PLoS One
- Post-translational modification of 14-3-3 isoforms and regulation of cellular function
- (2011) Alastair Aitken SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization
- (2010) Nicolas Dzamko et al. BIOCHEMICAL JOURNAL
- 14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
- (2010) R. Jeremy Nichols et al. BIOCHEMICAL JOURNAL
- Phosphopeptide Analysis Reveals Two Discrete Clusters of Phosphorylation in the N-Terminus and the Roc Domain of the Parkinson-Disease Associated Protein Kinase LRRK2
- (2010) Christian Johannes Gloeckner et al. JOURNAL OF PROTEOME RESEARCH
- Identification and Characterization of a Leucine-Rich Repeat Kinase 2 (LRRK2) Consensus Phosphorylation Motif
- (2010) Pooja P. Pungaliya et al. PLoS One
- Clinical features of LRRK2 parkinsonism
- (2009) Kristoffer Haugarvoll et al. PARKINSONISM & RELATED DISORDERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started